|
||||||||||||||
The NASDAQ Biotechnology Index includes securities of Nasdaq-listed companies classified according to the Industry Classification Benchmark as either Biotechnology or Pharmaceuticals which also meet other eligibility criteria. The NASDAQ Biotechnology Index is calculated under a modified capitalization-weighted methodology.
Index returns do not represent actual performance of the NASDAQ Biotechnology Index Fund and are for illustration only. Past performance is no guarantee of future results. For actual performance of the iShares NASDAQ Biotechnology Index Fund, request a prospectus by calling 1-800-iShares (1-800-474-2737) or contact your financial advisor. Biotechnology Index Security Eligibility Criteria
Semi-annual Ranking Review In addition to the Ranking Review, the securities in the Index are monitored every day by NASDAQ with respect to changes in total shares outstanding arising from secondary offerings, stock repurchases, conversions, or other corporate actions. NASDAQ has adopted the following weight adjustment procedures with respect to such changes. Changes in total shares outstanding arising from stock splits, stock dividends, or spin-offs are generally made to the Index on the evening prior to the effective date of such corporate action. If the change in total shares outstanding arising from other corporate actions is greater than or equal to 5.0%, the change will be made as soon as practicable, normally within ten (10) days of such action. Otherwise, if the change in total shares outstanding is less than 5%, then all such changes are accumulated and made effective at one time on a quarterly basis after the close of trading on the third Friday in each of March, June, September, and December. In either case, the Index share weights for such Index Securities are adjusted by the same percentage amount by which the total shares outstanding have changed in such Index Securities. For more information about this and other index based products check our Exchange Traded Funds area. |
| Data as of Feb. 22, 12 Mkt Close.
Click on the security's symbol for a Full Quote. |
|||||||||||||||
|
|||||||||||||||
In addition to the normal risks associated with equity investing, narrowly focused investments and investments in smaller companies typically exhibit higher volatility. Products of companies in which biotechnology funds invest may be subject to severe competition and rapid obsolescence. |
| |
|
Get Free Annual Reports | © Copyright | Disclaimer | Trademarks | Privacy Statement | Contact Us | Help | Site Map | Search | popular tags: stock quotes | online brokers | mutual funds | investing | stock ticker | forex trading | personal finance | credit cards |